Author | Diabetes type | Study population | Methodology | Intervention | |
---|---|---|---|---|---|
1 | Anderson et al. 2003 [15] | 98.5 % of intervention group patients are Type 2; 100 % of control group patients are Type 2 | n I = 67, n C = 65; African Americans; Patients with normal or mild eye exam; Detroit metropolitan area; United States (US). | Randomized Control Trial (RCT); Measurement: 12 months (mos). | Letter and phone reminder |
2 | Austin and Wolfe 2011 [24] | Not given | n I = 464, n C = 693; without HbA1c or LDL-C prior 12 mos; Midwestern university system; US. | Quasi-experimental; Measurement: 12 mos. | Letter reminder with a financial incentive |
3 | Avdal et al. 2011 [61] | Type 2 | n I = 61, n C = 61; diagnosis at least 6 mos, > 18 yrs old, on insulin, HbA1c > 7 %, completed diabetes education, can use computer and internet, and volunteered to participate; Turkey. | RCT; Measurements: baseline and 6 mos. | Web-based |
Exclusion: advanced retinopathy or neuropathy. | |||||
4 | Bailie et al. 2004 [62] | Type 2 | n B = 137, n 6 = 137, n 1 = 133, n 2 = 123, n 3 = 146; Aboriginal people, Australia. | Follow-up study over 3 years; Measurements: baseline, 6 mos, and year 1, 2, and 3. | Electronic Health Record (EHR); Evidence-based Guidelines |
5 | Benhamou et al. 2007 [63] | Type 1 | n = 30; ≥ 18 years old, on external insulin pump for 3 mos, and HbA1c 7.5 %-10 %; France. | Bicenter, open-label, randomized, two-period crossover study; 6 mos with SMS (short message service) followed by 6 mos without SMS or reverse sequence; Measurements: baseline and two 6-month periods. | Web-based; SMS |
Exclusion: retinopathy, pregnancy, unable to use software, out of mobile phone network, or unwilling to do 4 SMBG tests/day. | |||||
6 | Bond et al. 2006 [64] | Not given | n = 15; diabetes, age 60 or older; Washington, US. | Randomized in the first phase, pilot study | Web-based |
7 | Bond et al. 2007 [36] | 87 % Type 1, 13 % Type 2 | n I = 31;n C = 31; ≥ 60 years old; having diagnosed with diabetes for at least 1 year, living independently in the community, fluency in English, West coast university health system; US. | RCT; Randomized using two-tier strata (above and below 7.5 % HbA1c) and gender. Intervention subjects participated in one of two phases (each phase lasting one year); Measurements: baseline and 6 mos. | Web-based; Behavioral |
Exclusion: mod/severe cognitive, visual, or physical impairment or severe co-morbid disease. | |||||
8 | Carter et al. 2011 [37] | Type 2 | n I = 26, n C = 21; type 2 diabetes 2 yrs prior to study, ≥ 18 yrs old, African American, 8th grade reading level, residing in Washington, DC, willing provider; US. | RCT; Measurements: baseline and 9 mos. | Web-based; Behavioral |
Exclusion: visually or hearing impaired, non-English speaking, on dialysis or psychotropic meds. | |||||
9 | Cavan et al. 2003 [65] | Type 1 | n = 6; type 1 diabetes and attended one-hour training session; United Kingdom | Pilot study; Measurements: baseline, 3 and 6 mos, and year 1 and 2. | Web-based |
10 | Cherry et al. 2002 [46] | Not given | n = 169; indigent or economically disadvantaged adults, competent, have telephone, can read or have reading assistance, reside and have physician in Mercy Health Center, Laredo, TX service area; US. | Cohort; Measurements: baseline, quarterly for 2 quarters and 12 mos. | Web-based; Telephone data line; Behavioral |
11 | Cho et al. 2006 [57] | Type 2 | n I = 40, n C = 40; ≥ 30 yrs old, > 6 mos in center; South Korea. | Prospective, RCT; Measurements: baseline, 3-month intervals up to 30 mos. | Web-based |
Exclusion: disabling conditions, severe diabetes complications, intensified insulin regimen, no internet access, unwilling, or in similar programs. | |||||
12 | Cho et al. 2009 [66] | Type 2 | Internet: n = 37; diabetes phone: n = 38; internet access and uses mobile phone/SMS; South Korea. | Randomized, non-inferiority with active-controlled period; Measurements: baseline to 3 mos. | Diabetes Phone; Web-based; SMS |
Exclusion: heart failure, liver enzymes 2x normal, renal disease (creatinine > 1.5 mg/dL), in similar programs. | |||||
13 | Cho et al. 2011 [67] | Type 2 | n I = 35, n c = 36; age ≥ 40; HbA1c from 7.0 to 11.0 %; followed at least 6 months in a public healthcare post in rural areas of Chung-ju, Korea. | RCT; Measurements: Baseline and at 3 months. | Web-based; Phone call; Performance feedback |
Exclusion: diagnosed or suspected disease of liver, pancreas, endocrine organ, kidney; ischemic heart disease; cerebrovascular disease; creatinine >0.133 mmol/l; intensive insulin regimen; unable to attend regularly. | |||||
14 | Chumbler et al. 2005 [21] | Not given | n I = 400, n C = 400; ≥ 2 Veterans Administration (VA) hospitalizations or emergency visits in last year, telephone access, non-institutionalized; Florida, Puerto Rico and Georgia; US. | Retrospective, concurrent matched cohort; Measurements: 12 mos before and after. | Web-based; Telephone data line |
15 | Ciemins et al. 2009 [52] | Not given | n = 495; adult, provider visit in last year; central/eastern Montana and northern Wyoming; US. | Pre-post intervention, cohort; Measurements: 2 year baseline and two consecutive 2 year intervention periods. | EHR; Registry; Patient and provider report cards; Evidence-based guidelines |
Exclusion: gestational or steroid-induced diabetes, nursing home resident, prednisone use > 2 mos, or seen by endocrinologist for care and testing. | |||||
16 | de Grauw et al. 2002 [19] | Type 2 | n = 432 baseline, n = 594 follow-up; type 2 diabetes; Nijmegen Academic Research Network, the Netherlands. | Multicenter cross-sectional; Measurements: baseline and 6 yrs. | Registry; Phone reminder |
17 | Derose et al. 2009 [25] | Type 1 or 2 (based on ICD-9 codes) | n I.1 = 2916, n I.2 = 1934, n I.3 = 1933, n I.4 = 2199, n I.5 = 2200, n C = 1875; no HbA1c, LDL-C, and urinary microalbumin tests in > 1 yr, and birthday in 3 mos; Southern California Kaiser Permanent; US. | RCT; Measurements: 2 consecutive 3-month periods. | Letter and phone reminder |
18 | Dijkstra et al. 2005 [54] | 32 % of intervention group patients are Type 1, 33 % of control group patients are Type 1 | n I = 351, nC = 418 patients; n I = 4 n C = 5 hospitals; n I = 22, n C = 20 internists; the Netherlands. | Clustered, RCT; Measurements: baseline and post-intervention (time varied per indicator) | Patient-held record (PHR); Evidence-based guidelines |
19 | Edelman et al. 2010 [34] | Not given | n I = 133, n C = 106; hypertension and diabetes, on diabetes medication, HbA1c > 7.5 % and systolic BP > 140 mm Hg or diastolic BP > 90 mm Hg; North Carolina and Virginia, US. | RCT; Measurements: study midpoint (6.8 mos) and completion (12.8 mos). | Financial incentive; Group visit |
Exclusion: seen by endocrine clinic in past 6 mos, hospitalized for psychosis in past 3 yrs, cognitively impaired, or severe chronic illness. | |||||
20 | Edwards et al. 2012 [17] | Type 1 or 2 (based on ICD-9 codes) | n I = 94, n C = 210; age 18 and 85 yrs; diabetes patients who were scheduled for appointments with a primary care provider between 08/2010 and 04/2011; University of Oklahoma Family Medicine Center (FMC) in Oklahoma City, US. | RCT; Measurements: 1 year before the intervention, and immediate at intervention | Phone call; Evidence-based guidelines |
Exclusion: pregnant; recently seen in group visits; diabetes managed by a provider outside the FMC. | |||||
21 | Farmer et al. 2005 [68] | Type 1 | n I = 47, n C = 46; United Kingdom; age 18–30 yrs, basal bolus insulin, last 2 HbA1c tests 8 -11 %. | RCT, parallel-group; Measurements: baseline, 4 and 9 mos. | Web-based; SMS |
Exclusion: avoid tight glycemic control, another severe disease, cannot do SMBG, or other family member in trial. | |||||
22 | Fischer et al. 2011 [13] | Type 1 or 2 (based on ICD-9 codes) | Mailed report cards: n I = 2728, n C = 2729; Printable report cards: n I = 2357, n C = 3100; Provider report cards: n I = 2893, n C = 2564; >17 yrs, at least one visit to clinic within 18 mos; Denver, CO; US. | Nested randomized trial; Measurements: baseline and 13 mos. | Registry; Patient and provider report cards; Mail reminder |
Exclusion: >75 yrs, no mail address, cannot speak English or Spanish | |||||
23 | Fischer et al. 2012 [69] | Not given | n = 47; age ≥ 18 yrs; diabetes, have cell phone; fluent in English or Spanish; regularly receive healthcare at a federally qualified community health center in Denver, Colorado, US. | Quasi-experimental; Measurement: at 3 mos. | SMS; Phone call; Behavioral |
24 | Glasgow et al. 2003 [70] | Type 2 | n = 320; live by self for ≥ 1 yr; have phone; read and write English; diabetes for at least 1 yr and not moving out of area next yr; Kaiser Colorado, US. | RCT; 3 intervention groups: basic information, tailored self-management and peer support. Measurements: baseline and 10 mos. | Web-based; Behavioral |
25 | Glasgow et al. 2004 [58] | Type 2 | n I = 469, n C = 417 patients; n I = 24, n C = 28 physicians (all physicians in Diabetes Priority Program); type 2 diabetes, ≥ 25 yrs old, can read English; Colorado; US. | Two-group cluster, RCT; Measurements: baseline and 6 mos. | Web-based |
26 | Grant et al. 2008 [55] | Type 2 | n I = 126 n C = 118 patients, n = 11 practices; HbA1c > 7 % in prior yr, active diabetes prescription, ≥ 1 visit within prior yr, active account with patient web-portal; eastern Massachusetts; US. | RCT; Measurements: baseline and 12 mos. | Web-based |
27 | Harno et al. 2006 [71] | Type 1 or 2 | n I = 101, n C = 74; type 1 or type 2 diabetes; 2 university hospital outpatient clinics; Finland. | RCT; Measurements: baseline and 12 mos. | Web-based; SMS |
28 | Holbrook et al. 2009 [28] | Type 2 | n I = 253, n C = 258; ≥ 18 yrs old, fluent in English and able to understand the study description; Ontario, Canada. | Pragmatic RCT; Measurements: baseline and 6 mos. | Web-based; Phone reminder, Behavioral |
29 | Hurwitz et al. 1993 [72] | Type 2 | n = 187; non-insulin dependent diabetes mellitus, ≤ 80 yrs old, attend clinic ≥ 2 yrs; United Kingdom. | RCT; Measurements: baseline and 2 yrs. | Letter and phone reminder |
Exclusion: women of childbearing age or patients with significant diabetic complications. | |||||
30 | Jones and Curry 2006 [50] | Type 2 | n I = 58, n C = 115; 2 provider visits during study, and ≤ 1 provider visit in opposite group; Pennsylvania; US | Non-randomized clinical trial; historical control group; Measurements: baseline and within 16 mos after intervention. | Personal digital assistant; Provider reminder; Letter reminder; Evidence-based guidelines |
31 | HS Kim et al. 2005 [44] | Type 2 | n = 42; able to do SBMG and self-injection of medication, access to web sites and cellular phone; South Korea. | Quasi-experimental, one group, pretest-posttest; Measurements: baseline and 12 weeks. | Web-based; SMS |
Exclusion: severe illness, renal insufficiency (creatinine > 1.5 mg/dL) or on insulin pump. | |||||
32 | HS Kim et al. 2006 [42] | Type 2 | n = 33; ≥ 30 yrs old, can do SMBG tests and medication injection, can input data to web, internet access, and cellular phone; South Korea. | Quasi-experimental, one group, pretest-posttest; Measurements: baseline and 12 weeks. | Web-based; SMS |
Exclusion: heart failure, hepatic dysfunction, renal insufficiency, on insulin pump or other diabetes web offer. | |||||
33, 34 | Type 2 | n I = 25, n C = 26; able to do SBMG and self-injection of medication, access to web sites and cellular phone; South Korea. | Control group, pretest-posttest, randomized by random permuted block design; Measurements: baseline, and 3 mos. | Web-based; SMS; Behavioral | |
Exclusion: severe illness, renal insufficiency, or on insulin pump. | |||||
35 | HS Kim and Jeong 2007 [41] | Type 2 | n I = 25, n C = 26; able to do SBMG and self-injection of medication, able to input data to web site, had home internet access, and cellular phone; South Korea. | Control group, pretest-posttest, randomized by random permuted block design; Measurements: baseline, 3, and 6 mos. | Web-based; SMS |
Exclusion: severe illness, renal insufficiency, or on insulin pump. | |||||
36 | HS Kim and Song 2008 [43] | Type 2 | n I = 18, n C = 16; ≥ 30 yrs old, obese, able to do SBMG and self-medication, able to input data to web site, had home internet access, and cellular phone; South Korea. | Quasi-experimental, repeated measures, pretest-posttest; Measurements: baseline, 3, and 6 mos. | Web-based; SMS |
Exclusion: heart failure, hepatic dysfunction, renal insufficiency, or on insulin pump. | |||||
37 | SI Kim and HS Kim 2008 [73] | Type 2 | n I = 18, n C = 16; able to do SBMG and self-injection of medication, access to web sites and cellular phone; South Korea. | Quasi-experimental, repeated measures, pretest-posttest; Measurements: baseline, 3, 6, 9, and 12 mos. | Web-based; SMS |
Exclusion: severe illness, renal insufficiency, or on insulin pump. | |||||
38 | Kirsh et al. 2007 [12] | Type 2 | n I = 44, n C = 35; one or more of following: A1c > 9 %, SBP >160 mm Hg and LDL-c >130 mg/dl; Veterans Healthcare System; US. | Quasi-experimental, non-randomized concurrent controls; Measurements: baseline and 6 mos | Letter reminder |
39 | Kwon et al. 2004 [74] | Type 2 | n I = 51, n C = 50; type 2 diabetes ≥ 1 yr, internet access, ≥ 30 yrs old; South Korea. | RCT; Measurements: baseline and 12 weeks. | Web-based |
Exclusion: significant diseases likely to affect outcome (heart failure, hepatic dysfunction, renal insufficiency or on insulin pump). | |||||
40 | Kwon et al. 2004 [45] | 16.2 % Type 1, 82.7 % Type 2, 1.1 % secondary diabetes | n = 185; diabetes ≥ 1 yr, internet access; South Korea. | Non-randomized cohort; Measurements: baseline and 3 mos. | Web-based; SMS |
Exclusion: significant diseases likely to affect outcome (hepatic or renal failure). | |||||
41 | Lafata et al. 2002 [14] | Type 1 or 2 (based on ICD-9 codes) | n I = 1641, n C = 1668; in patient registry, ≥ 18 yrs and ≥ 2 diabetes visits or at least 1 pharmacy claim for diabetes drug in last 24 mos; Michigan, US | RCT; Measurements: 6 and 12 mos. | Letter reminder |
42 | Lin et al. 2007 [29] | Not given | n I = 33, nC = 35; Canadian primary care center. | Historical cohort; Measurements: baseline and 3 years. | Phone reminder; Evidence-based guidelines; Longer appointments |
Exclusion: no family doctor and those without at least 2 diabetic follow-up appointments. | |||||
43 | Litzelman et al. 1993 [75] | Type 2 | n I = 191, n C = 205; non-insulin dependent diabetes, ≥ 2 visits in prior yr, > 40 yrs old, diabetes diagnosis after age 30, 2 yrs with practice, and ideal or heavier than ideal body weight, at risk of lower-extremity amputation; Indianapolis; US. | RCT; Measurements: baseline and 12 mos. | Phone and postcard reminder; Behavioral |
Exclusion: pregnancy, major psychiatric illness, dementia, terminal illness (death in 1 yr), renal failure, bilateral amputations and investigator’s patients. | |||||
44 | Lorig et al. 2010 [76] | Type 2 | n I.1 = 209, n I.2 = 186, n I.3 = 395, n C = 238; aged ≥ 18 yrs, not pregnant or in cancer care, physician verified type 2 diabetes diagnosis and access to the Internet. Effort to recruit American Indians/Alaskan Natives; California; US. | RCT; Measurements: baseline, 6, and 18 mos. | Web-based |
45 | Maclean et al. 2009 [20] | Type 1 or 2 | n I = 3886, n C = 3526 patients; n I = 70, n C = 62 physicians; n I = 30, n C = 34 practices; HbA1c in last 2 yrs; Vermont and New York; US. | RCT; Practices randomized in blocks by hospital laboratory; Measurements: 32 mos. | Registry; Decision support; Fax and Letter reminder |
Exclusion: < 18 yrs, cognitive impairment or provider decision. | |||||
46 | McCarrier et al. 2009 [77] | Type 1 | n I = 41, n C = 36; 21–49 yrs old, ≥ 2 encounters and at least 1 HbA1c in prior yr, recent HbA1c >7% and reside in King or Snohomish County, Center, Washington; US. | Randomized, pretest-posttest trial; Measurements: 12 mos. | Web-based |
47 | McDermott et al. 2001 [32] | Not given | n = 282 patients at 8 intervention sites, n = 396 patients at 13 control sites; mostly Torres Strait Islanders, Australia | Randomized unblended, cluster trial; Measurements: baseline and 12 mos. | Registry; Evidence based guidelines |
48 | McDiarmid et al. 2001 [51] | Type 2 | n = 258; urban family practice residency, Greensboro, North Carolina; US. | Non-randomized, before/after, retrospective chart audit; Measurements: baseline and 12 mos. | Evidence-based guidelines |
49 | McMahon et al. 2005 [78] | Not given | n I = 52, n C = 52; HbA1c ≥ 9 %, age > 18 yrs, understands written and spoken English, willingness to use notebook computer, glucose and BP devices; Boston VA Healthcare System; US. | RCT; Measurements: baseline, 3, 6, 9 and 12 mos. | Web-based |
50 | McMahon et al. 2012 [47] | Type 2 | n I.1 = 51, n I.2 = 51, n I.3 = 49; age > 25 yrs, HbA1c > 8.5 %, understand written and spoken English, access to phone, willingness to use laptop, and BP and glucose monitoring devices, have a VA-based primary care provider; Boston, MA; US. | RCT; Measurements: 3, 6, 9, and 12 mos. | Web-based; Phone calls; Performance feedback |
51 | Mehler et al. 2005 [79] | Type 2 | n I.1 = 415, n I.2 = 146, n C = 323 patients at 12 primary care practices; age ≥ 40 yrs; Denver-metro area; US. | Stratified and randomized by practice type (family medicine, internal medicine or academic); Measurements: baseline and 15 mos. | Evidence-based guidelines |
52 | Meigs et al. 2003 [49] | Type 2 | n I = 307 patients, n I = 12 providers; n C = 291 patients, n C = 14 providers; hospital-based staff-resident medical practice; Boston, Massachusetts; US. | RCT; Measurements: 12 mos pre-intervention and 12 mos post-intervention. | Web-based; Decision support; Evidence-based guidelines |
53 | Meulepas et al. 2007 [30] | Type 2 | n I = 353 patients, n I = 51 providers; n C = 129 patients, n C = 27 providers; documented diabetes for > 4 yrs at start of study; The Netherlands | Controlled, non-randomized, before/after study with delayed intervention in control group; Measurements: 1 yr before intervention and 2 years after. | Phone reminder |
54 | Meulepas et al. 2008 [31] | Type 2 | n I = 431 patients, n I = 23 providers; n C = 469 patients, n C = 28 providers; in the south of The Netherlands | Controlled, non-randomized study, before/after; Measurements: 1 yr before intervention and 2 years after. | Phone reminder |
55 | Moattari et al. 2013 [80] | 97 % Type 1 | n I = 24, n C = 24; have diabetes, need insulin, ability to use glucometer and inject insulin, ability to input data on a website, own cellphone; Shiraz, Iran. | RCT; Measurements: baseline and 3 mos. | Web-based; Phone; SMS |
Exclusion: chronic disease or renal failure (creatinine > 1.5 mg/dl), use of insulin pump, pregnancy. | |||||
56 | Moorman et al. 2012 [81] | Not given | n C = 19, n I = 18; Adult diabetic patients not working with a case manager, at least one request for a self-monitoring blood glucose log, Ohio, US | Cohort study; Measurements: 3 mos. before the intervention and 3 mos. after. | Letter reminder |
Exclusion: No documented mailing address | |||||
57 | Musacchio et al. 2011 [82] | Type 2 | n = 1004; HbA1c < 7 %, ability to follow educational program, and clinical data for prior 12 mos; Italy. | Pre-post study; Measurements: baseline and 12 mos. | Tele-medicine (phone and internet); EHR; Behavioral |
58 | Nes et al. 2012 [83] | Type 2 | n = 11; type 2 diabetes, no other inclusion/exclusion criteria reported; Oslo, Norway | Snowball sample pilot study; baseline and 3 mos. | Web-based; Performance feedback |
59 | Piette et al. 2000 [84] | Not given | n = 248; English or Spanish speaking adults; California; US. | Randomized control trial; Measurements: baseline and 12 mos. | Automated phone call |
Exclusion: >75 yrs, psychotic, sensory impairment, or life expectancy <12 mos, on hypoglycemic medication, diabetes ≤ 6 mos, plan to stop clinic services during study period, no push-button phone. | |||||
60 | Rai et al. 2011 [18] | Type 1 or 2 (based on ICD-9 codes) | n I = 1765, n C = 1315; 2 diabetes and hypertension ICD-9 codes in billing data in past 2 yrs; no provider visit in last 6 mos; Wisconsin; US. | Quasi-experimental; Measurement: 6 mos. | Phone reminder |
Exclusion: patient without history of treatment by provider. | |||||
61 | Ralston et al. 2009 [38] | Type 2 | n I = 39, n C = 35; 18–75 yrs old, last HbA1c ≥ 7 %, at least two visits in prior year; University of Washington; US. | Randomized, single-centered, controlled trial with parallel group design; Measurements: 12 mos before intervention and 12 mos after. | Web-based; Decision support |
Exclusion: in pilot, psychological illness, non-English speaking, resident as provider or mostly specialty care. | |||||
62 | Ryan et al. 2013 [85] | Type 2 | n I = 24; age 21 and older; established patient; seen at least once for diabetes management during the previous 12 months; Most recent A1c < 10; last A1c within last 6 months; a community health clinic in Miami, Florida, US. | Pretest-posttest; Measurements: baseline and 13 mos. | Web-based |
Exclusion: Did not speak English; had an emergency room discharge or hospital admission for a diabetes-related complication during the 6 months before recruitment; were homeless or did not have control of the given living situation; had significant cognitive impairment or psychological distress; had known substance or alcohol abuse. | |||||
63 | Sacco et al. 2009 [48] | Type 2 | n I = 31, n C = 31; age18 – 65 yrs, reads and speaks English, reachable by phone, HbA1c > 6.5 %, cardiovascular risk factor; Florida; US | Randomized, pretest-posttest; Measurements: baseline and 6 mos. | Behavioral; Phone coaching |
Exclusion: major medical/mental disorder. | |||||
64 | Sadur et al. 1999 [22] | Type 1 or 2 | 16-75 yrs old, recent HbA1c > 8.5 % or no HbA1c in last year; Kaiser; California; US. | RCT; Measurements: baseline and 6 mos. Hospitalization rate measured 12 mos before intervention and 18 mos after. | Group visit; Phone; Behavioral |
Exclusion: pregnancy, dementia, no English, cannot attend monthly meetings. | |||||
65 | Seto et al. 2012 [16] | Type 1 or 2 | n I = 580; age 18 and older; seen at the health center between July 1, 2009 and June 30, 2010; a primary care clinic in San Jose, California, US. | Pretest-posttest; Measurements: baseline and 7 mos. | Registry; Appointment reminder |
Exclusion: No baseline A1c; gestational diabetes | |||||
66 | DM Smith et al. 1987 [27] | Not given | n I = 425, n C = 429; patients with insulin or oral hypoglycemic agents prescribed, reported all care received at center, not residents of nursing home or other institution, ≥ 15 yrs old, visited clinic in last yr and had scheduled appointment to return to clinic; metropolitan Indianapolis; US. | RCT; Measurement: 2 yrs. | Letter and phone reminder |
67 | KE Smith et al. 2004 [86] | Type 1 or 2 | n = 16; ≥ 18 yrs old, no unstable cardiac disease or organ transplantation, can read computer monitor, and HbA1c > 8.5 %; Georgetown University Hospital; US. | Non-randomized, prospective feasibility; Measurements: baseline and 6 mos. | Web-based |
68 | Song et al. 2009 [87] | Type 2 | n I.1 = 15, n C = 16; adults, new diagnosis type 2 diabetes, never attended formal self-management education by health professional or over internet; Seoul, Korea. | Quasi-experimental, non-equivalent control group, pretest-posttest; Measurements: baseline, 6 weeks, and 3 mos. | Web-based; Behavioral |
69 | Stone et al. 2012 [88] | Not given | n I.1 = 21, n I.2 = 23, n I.3 = 28, n I.4 = 29; age 18–79 yrs; diagnosis defined as 12 or more months of pharmacologic treatment for diabetes; HbA1c ≥ 7.5 %; no comorbid conditions indicating life expectancy of less than 5 years; private residence with telephone land line; VA Healthcare System, Pittsburgh, Pennsylvania, US. | RCT; pretest-posttest; Measurements: baseline, 3, and 6 mos. | Tele-monitoring (phone); Performance feedback |
Exclusion: Did not have a telephone landline. | |||||
70 | Subramanian et al. 2009 [23] | Type 2 | n I = 3147, n C = 913; prescription refill for hypoglycemic agent without polycystic ovarian disease, HbA1c ≥ 9 % or elevated FBS ≥ 200 mg/dL; Indianapolis; US. | Retrospective, cohort; Measurements: 1 yr before intervention and 1 yr after. | Open access (OA) |
Exclusion: missing all lab tests, vital signs, or visit data in study period. | |||||
71 | Tang et al. 2013 [89] | Type 2 | n I = 193, n C = 189; age ≥ 18 yrs; HbA1c ≥ 7.5 %; seen within the past 12 months; a not-for-profit healthcare organization in Palo Alto, California, US. | RCT; Measurements: Baseline, 6 and 12 mos. | Web-based; Performance feedback; EHR; Behavioral |
Exclusion: initial diagnosis within the last 12 months; inability to speak or read English; lack of regular internet access; unwillingness to perform self-monitoring at home; diagnosis of a terminal disease and/or entry into hospice care; pregnancy, planning pregnancy or currently lactating; enrollment in another care management program; resident of a long-term facility; uninsured; plans to discontinue primary care at current location; family household member enrolled in EMPOWER-D study. | |||||
72 | Thomas et al. 2007 [26] | Not given | n I = 78 resident physicians, n C = 39; Internal Medicine residents; Mayo Clinic, Minnesota; US. | RCT; Randomization stratified by clinic day across 5 practice sections; Measurements: baseline and completion including prior 6 mos for HbA1c and prior 12 mos for lipids. | Registry; Evidence-based guidelines; Performance feedback; Letter reminder |
73 | Tildesley et al. 2010 [90] | Type 2 | n I = 24, n C = 23; on insulin alone or with oral hypo-glycemic medication, recent HbA1c >7.0 %, internet access, and training in SMBG; Vancouver, Canada | RCT; Measurements: baseline, 3 and 6 mos. | Web-based; Performance feedback |
74 | Weber et al. 2008 [53] | Not given | Gesinger Health System of 38 practice sites and > 20,000 diabetes patients >18 years old in 40-county region of central and northeastern Pennsylvania; US. | Retrospective, cohort; Measurements: baseline time period (12 mos before) and monthly after implementation of intervention for 12 mos. | Registry; Evidence-based guidelines; Provider reminder; Performance feedback |
75 | Yeh et al. 2006 [33] | Type 2 | n I = 134, n C = 140; medical teaching hospital in Taipei, Taiwan | RCT; Measurements: pre-intervention and post-intervention (8 month follow-up). | Web-based; SMS; |
76 | Yoo et al. 2009 [91] | Type 2 | n I = 57, n C = 54; age 30 and 70 yrs; hypertension and type 2 diabetes diagnoses in last year; HbA1c 6.5–10.0 %; BP > 130⁄80 mmHg; BMI ≥ 23.0 kg⁄m2; Seoul, Korea. | RCT; Measurements: base line and 3 mos. | Web-based; Phone reminder; Telephone data line; Automated performance feedback; SMS |
Exclusion: Severe diabetic complications; liver dysfunction with enzymes >2.5x normal, or renal dysfunction, diagnoses of heart failure, angina, myocardial infarction, or stroke, pregnancy or lactation. | |||||
77 | Yoon and HS Kim 2008 [92] | Type 2 | n I = 25, n C = 26; ability to perform SBMG, access websites, and cellular phone with web access; university medical center, urban city of South Korea. | RCT, pretest-posttest; Measurements: baseline, 3, 6, 9, and 12 mos. | Web-based; SMS |
Exclusion: severe illness, renal insufficiency with creatinine > 1.5 mg/dL or on insulin pump. |